Your session is about to expire
← Back to Search
3D Echocardiography for Heart Function Assessment in Children
N/A
Waitlist Available
Led By David M Harrild, MD, PhD
Research Sponsored by Boston Children's Hospital
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Be younger than 65 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 0 days
Awards & highlights
Study Summary
This trial will compare the accuracy of two methods for measuring RV volumes, with CMR as the gold standard.
Who is the study for?
This trial is for pediatric patients under 18 years old who are scheduled to undergo Cardiac Magnetic Resonance (CMR) imaging for clinical reasons. It's not open to anyone over the age of 18.Check my eligibility
What is being tested?
The study is testing how well three-dimensional echocardiography measures the volume of the right side of the heart in children, comparing images from two different angles: apical and subcostal, against CMR, which is considered the gold standard.See study design
What are the potential side effects?
Since this trial involves non-invasive imaging techniques like echocardiography and CMR, there are minimal risks involved. The main concerns would be discomfort or anxiety during image acquisition.
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ 0 days
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~0 days
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Primary outcome measures
Mean absolute %error in end diastolic volume measurements
Secondary outcome measures
Mean absolute %error in RVEDV/RVESV/RVEF (subcostal window)
Mean absolute %error in right ventricular end systolic volume (RVESV) / right ventricular ejection fraction (RVEF)
Trial Design
1Treatment groups
Experimental Treatment
Group I: Patients undergoing Cardiac MRIExperimental Treatment1 Intervention
Patients scheduled to undergo cardiac magnetic resonance for clinical reason will be asked if they are willing to undergo additional non invasive testing (three-dimensional echocardiography) which will take about 15-20 minutes
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
three-dimensional echocardiography
2019
N/A
~50
Find a Location
Who is running the clinical trial?
Boston Children's HospitalLead Sponsor
763 Previous Clinical Trials
5,580,579 Total Patients Enrolled
David M Harrild, MD, PhDPrincipal InvestigatorBoston Children's Hospital
Media Library
Eligibility Criteria:
This trial includes the following eligibility criteria:Research Study Groups:
This trial has the following groups:- Group 1: Patients undergoing Cardiac MRI
Awards:
This trial has 1 awards, including:- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
Timeline:
This trial has the following timeline:- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Is enrollment for this experiment open currently?
"According to clinicaltrials.gov, this medical trial is not presently enrolling participants as it was last edited on June 6th 2022. However, there are 1 other studies actively looking for patients at the moment of writing."
Answered by AI
Recent research and studies
Other Trials to Consider
Popular Categories
Share this study with friends
Copy Link
Messenger